Science and Technology
Science and Technology
Thu, December 12, 2024
[ 07:42 AM ] - United States, Ghanaweb.com
[ 07:42 AM ] - United States, moneycontrol.com
[ 07:22 AM ] - United States, Mint
[ 07:22 AM ] - United States, Business Standard
[ 07:02 AM ] - United States, Nuclear Engineering International
[ 07:02 AM ] - United States, Science Daily
[ 07:02 AM ] - United States, Ghanaweb.com
[ 06:42 AM ] - United States, Flightglobal
[ 06:22 AM ] - United States, KGOU
[ 06:02 AM ] - United States, MSN
[ 05:42 AM ] - United States, MSN
[ 05:42 AM ] - United States, Association for Psychological Science
[ 05:42 AM ] - United States, Ghanaweb.com
[ 03:22 AM ] - United States, SciTech Daily
[ 02:42 AM ] - United States, Daily Express
[ 01:02 AM ] - United States, The Irish Times
[ 12:22 AM ] - United States, Science Daily
[ 12:22 AM ] - United States, Science Daily
[ 12:22 AM ] - United States, Science Daily
[ 12:22 AM ] - United States, brandequity.economictimes.indiatimes
Wed, December 11, 2024
[ 11:42 PM ] - United States, Analytics Insight
[ 11:22 PM ] - United States, Business Insider
[ 10:42 PM ] - United States, The Hindu
[ 10:24 PM ] - United States, Science Daily
Enabling AI to explain its predictions in plain language
Published on 2024-12-11 22:24:19 - Science Daily
- Researchers developed a system that converts AI explanations into narrative text that can be more easily understood by users. This system could help people determine when to trust a model's predictions.
The article from ScienceDaily discusses a study published in the journal *Nature Communications* that explores the potential of using a common cold virus, specifically a modified strain of the Coxsackievirus B3 (CVB3), as a treatment for cancer. Researchers found that this virus can selectively infect and kill cancer cells while sparing healthy cells. The study highlights how the virus triggers an immune response that not only destroys the cancer cells directly but also enhances the body's immune system to fight against remaining cancer cells. This approach, known as oncolytic virotherapy, has shown promising results in preclinical models, suggesting a new avenue for cancer therapy that could be less toxic than traditional chemotherapy and radiation. The research team is now working on optimizing the virus for human trials, aiming to improve its safety and efficacy.
Read the Full Science Daily Article at:
[ https://www.sciencedaily.com/releases/2024/12/241210163517.htm ]
Read the Full Science Daily Article at:
[ https://www.sciencedaily.com/releases/2024/12/241210163517.htm ]
Contributing Sources